April 15, 2010
COPENHAGENDanisco has extended its licensing agreement with Fonterra Cooperative Group for the production and marketing of their premium probiotic strains, HOWARU® Bifido and Rhamnosus, with the new terms extending from five to 10 years.
The agreement also expands territory and applications meaning global access for dairy products, liquid and powdered beverages, such as juices, waters and sports drinks, dietary supplements, meats, cheeses, cereals, confectionery and straws. In addition, there will no longer be restrictions on therapeutic fields, thus broadening the scope for the development of clinical studies and health claims.
Danisco is pleased with the new agreement, said Scott Bush, vice president of Marketing Health & Nutrition, Danisco. The expanded terms mean Danisco can offer HOWARU Bifido and Rhamnosus, two of the most highly documented probiotic strains on the market, to customers anywhere in the world for a total range of applications and benefits.
You May Also Like